Status:

COMPLETED

B-type Natriuretic Peptide (BNP)-Guided Diagnostic Strategy in Intensive Care Unit (ICU) Patients With Respiratory Failure

Lead Sponsor:

University Hospital, Basel, Switzerland

Collaborating Sponsors:

Swiss National Science Foundation

Conditions:

Respiratory Insufficiency

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Heart failure is a common reason for respiratory failure in ICU patients. The rapid and accurate differentiation of heart failure from other causes of respiratory failure remains a clinical challenge....

Detailed Description

Background: Respiratory failure is not only the most important reason for admission of patients to a medical intensive care unit (ICU), but also a common reason for the deterioration of patients alrea...

Eligibility Criteria

Inclusion

  • Patients presenting with primary or secondary respiratory failure in the ICU

Exclusion

  • Age \<18 years
  • Obvious traumatic cause
  • Renal dysfunction (serum creatinine \>250umol/l)
  • Sepsis
  • Cardiopulmonary reanimation within the last 12 hours
  • Shock
  • Respiratory insufficiency triggered during bronchoscopy

Key Trial Info

Start Date :

December 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2008

Estimated Enrollment :

286 Patients enrolled

Trial Details

Trial ID

NCT00130559

Start Date

December 1 2003

End Date

March 1 2008

Last Update

October 19 2011

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

University Hospital Basel, Medical ICU

Basel, Canton of Basel-City, Switzerland, 4031

2

University Hospital Basel, Surgical ICU

Basel, Canton of Basel-City, Switzerland, 4031

3

Hospital of Interlaken

Interlaken, Canton of Bern, Switzerland, 3800

4

Hospital of Thun

Thun, Canton of Bern, Switzerland, 3600

B-type Natriuretic Peptide (BNP)-Guided Diagnostic Strategy in Intensive Care Unit (ICU) Patients With Respiratory Failure | DecenTrialz